Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease
Francesco Nonino·Edo Richard·L. Sambati·Cinzia Del Giovane·Elisa Baldin·Maria Chiara Bassi·Claudia De Santis·Marien Gonzalez-Lorenzo·Luca Vignatelli·Graziella Filippini·Silvia Minozzi